Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
Natural Beauty Bio-Technology 9-Day RSI Related Terms
NBBTF vs PG, CL, KVUE: 9-Day RSI Comparison
For the Household & Personal Products subindustry, Natural Beauty Bio-Technology's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Natural Beauty Bio-Technology 9-Day RSI vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Natural Beauty Bio-Technology's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where Natural Beauty Bio-Technology's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Natural Beauty Bio-Technology (NBBTF) has a 9-Day RSI of 75.29 as of Jul. 17, 2026. According to the industry distribution chart, Natural Beauty Bio-Technology ranks #1187 out of 2108 companies in the Consumer Packaged Goods industry, placing it in the top 56.3%.
Is Natural Beauty Bio-Technology's 9-Day RSI too high?
Natural Beauty Bio-Technology's current 9-Day RSI is 75.29. The Consumer Packaged Goods industry median 9-Day RSI is 52.14. Natural Beauty Bio-Technology's value of 75.29 is 44.4% above this industry median. Based on the distribution chart, Natural Beauty Bio-Technology ranks #1187 out of 2108 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Natural Beauty Bio-Technology has a GF Score™ of 41/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Natural Beauty Bio-Technology's 9-Day RSI compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Natural Beauty Bio-Technology ranks #1187 out of 2108 companies for 9-Day RSI. This places Natural Beauty Bio-Technology in the lower half of its industry. The industry median 9-Day RSI is 52.14. Natural Beauty Bio-Technology's value of 75.29 is 44.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Consumer Packaged Goods company?
The median 9-Day RSI among Consumer Packaged Goods companies is 52.14, based on 2,108 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Natural Beauty Bio-Technology's current 9-Day RSI of 75.29 is 44.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Consumer Packaged Goods industry, the median 9-Day RSI is 52.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Natural Beauty Bio-Technology's current 9-Day RSI is 75.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Natural Beauty Bio-Technology stock overvalued right now?
Based on GuruFocus' analysis, Natural Beauty Bio-Technology (NBBTF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.11, compared to a current price of $0.06 — trading 44.4% below its estimated fair value. The current 9-Day RSI is 75.29 and 44.4% above the Consumer Packaged Goods industry median of 52.14. Natural Beauty Bio-Technology's overall GF Score™ is 41/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For Natural Beauty Bio-Technology (NBBTF), the current 9-Day RSI is 75.29 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Natural Beauty Bio-Technology (NBBTF) Overvalued in 2026?
Based on GuruFocus' analysis, Natural Beauty Bio-Technology stock appears to be undervalued.
The current stock price of $0.06 is trading 44.4% below its estimated GF Value™ of $0.11.
GuruFocus considers Natural Beauty Bio-Technology to be Significantly Undervalued.
Key valuation signals for NBBTF:
9-Day RSI: 75.29
GF Value™: $0.11 vs. price of $0.06 (44.4% below fair value)
Industry Position: 44.4% above the Consumer Packaged Goods median (#1187 of 2108)
No single metric tells the full story. See the NBBTF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Natural Beauty Bio-Technology Business Description
Natural Beauty Bio-Technology Ltd operates as an investment holding company. It is engaged in the manufacturing and selling of skincare, beauty, and aromatherapeutic products. Its products include the provision of skin treatments, beauty and spa services, and skincare consulting and beauty training services. The company's spas provide various services, including hydrotherapy, facial treatment, body care, and skincare analysis. The company derived its key revenue from franchised spas, self-owned spas, and concessionary counters at department stores. Geographically, it has three segments, which include the PRC, Taiwan, and Others (Hong Kong and Malaysia). Its key revenue is generated from the PRC.
41GF Score
Get the complete analysis for NBBTF
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NBBTF has been successfully added to your 
